-
currently because novel therapies replacing orexin are being developed by the pharmacological industry; prospects for a career in academic or industry are high. In parallel with this effort, we are also
-
introduced by our group while developing new ones, and we couple this work with innovative strategies to define the molecular basis for their modes of action in bacterial cells. In parallel, we investigate how
-
associated with biological membranes, including large peripheral membrane complexes and integral membrane transporters. In parallel with mechanistic structural work, we develop targeted chemical probes
-
, and fostering collaborative research with academic and industry partners. Required Qualifications: The post-doctoral fellow candidate is required to have obtained an MD, PhD, or MD/PhD in area of